Literature DB >> 25074982

Experience with oral betamethasone in extremely low birthweight infants with bronchopulmonary dysplasia.

Tatiana Smolkin1, Irena Ulanovsky1, Huda Jubran1, Shraga Blazer1, Imad R Makhoul1.   

Abstract

Entities:  

Keywords:  Neonatology; Respiratory

Mesh：

Substances：

Year:  2014        PMID： 25074982     DOI： 10.1136/archdischild-2014-306619

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN： 1359-2998            Impact factor:   5.747


× No keyword cloud information.
  5 in total

Review 1.  Postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia in preterm infants.

Authors:  Brigitte Lemyre; Michael Dunn; Bernard Thebaud
Journal:  Paediatr Child Health       Date:  2020-08-01       Impact factor: 2.253

Review 2.  Early (< 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.

Authors:  Lex W Doyle; Jeanie L Cheong; Susanne Hay; Brett J Manley; Henry L Halliday
Journal:  Cochrane Database Syst Rev       Date:  2021-10-21

3.  Where Are We Now with the Role of Steroids in the Management of Bronchopulmonary Dysplasia in Extremely Premature Babies?

Authors:  Matthew Hurley; Jayesh Mahendra Bhatt
Journal:  Front Pediatr       Date:  2016-08-10       Impact factor: 3.418

4.  Long non-coding RNA MALAT1 protects preterm infants with bronchopulmonary dysplasia by inhibiting cell apoptosis.

Authors:  Cheng Cai; Jiajun Qiu; Gang Qiu; Yihuan Chen; Zhijun Song; Juan Li; Xiaohui Gong
Journal:  BMC Pulm Med       Date:  2017-12-13       Impact factor: 3.317

5.  Adrenomedullin regulated by miRNA-574-3p protects premature infants with bronchopulmonary dysplasia.

Authors:  Xiaohui Gong; Jiajun Qiu; Gang Qiu; Cheng Cai
Journal:  Biosci Rep       Date:  2020-05-29       Impact factor: 3.840
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.